Why Evaluate Drug Transporters In Drug Development

A Scientific Perspective on Evaluation of Transporters in Drug Development

Why evaluate drug transporters in drug development?

DrugTransporter

Drug Transporters in ADME and Drug Action with Dr. Joseph Ware

NIH Clinical Center

Comprehensive In Vitro Approach to Evaluating Transporter-mediated Drug Interactions

Eurofins Discovery

Evaluating the Kidney Chip for Transporter Mediated Drug Drug Interactions Applications

Transporter Mediated Drug-Drug Interactions: A Case Study

In Vitro DDI Drug Transporter Studies ADME 101 Webinar: Efflux and Uptake Transporters

Transporter Mediated Drug-Drug Interactions: A Case Study with Dr. Jomy M. George

NIH Clinical Center

Enhancing Drug Development through Improved Screening Strategies

Technology Networks

Drug Transporter Webinar: Evaluation of Ketoconazole & Alt. Clinical CYP3A4-5 Inhibitors

P-Glycoprotein and Drug Transport Part 2 of 2 with Dr. Matthew Hall

NIH Clinical Center

Evaluating Transport Of Drug Delivery Systems Across Cellular Barriers l Protocol Preview

JoVE (Journal of Visualized Experiments)

Drug Development Challenges

BASF

Transporters of Emerging Importance in Drug Development: Beyond the Guidance Documents

Drug Transporters in Anticancer Drug Pharmacology

CU Cancer Center

Transporters in Drug Development Symposium

Biopharma Taiwan

Drug Transport Across the Blood Brain Barrier with Dr. Sadhana Jackson

NIH Clinical Center

Hepatic Transporters and Clearance: Emerging Methods to Improve Drug Candidate Selection

Qualyst Account

A Regulators Viewpoint: Strategies to Evaluate Microphysiological Systems for Drug Development

AAPS GOC 3 Drug Transporters and Oral Drug Absorption: Polli

American Association of Pharmaceutical Scientists